MicroRNA-410 reduces the expression of vascular endothelial growth factor and inhibits oxygen-induced retinal neovascularization

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Chen, Na ^a,b   Wang, Jiaqi ^c   Hu, Yijun ^c   Cui, Bei ^d   Li, Wenjie ^b   Xu, Guixia ^c   Liu, Lin ^a   Liu, Shanrong ^c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d NAVY GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; EYE DROPS; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; MICRORNA 200B; MICRORNA 410; MICRORNA 590 5P; OXYGEN; UNCLASSIFIED DRUG; VASCULOTROPIN A; 3' UNTRANSLATED REGION; MICRORNA; MIRN410 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG BINDING; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN TARGETING; RETINA NEOVASCULARIZATION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; UPREGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICRORNAS; OXYGEN; RETINAL NEOVASCULARIZATION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899721018     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095665     Document Type: Article

References (63)

1. Takagi H (2003) Molecular mechanisms of retinal neovascularization in diabetic retinopathy. Intern Med 42: 299-301.
2. Hayreh SS, Zimmerman MB (2012) Ocular neovascularization associated with central and hemicentral retinal vein occlusion. Retina 32: 1553-1565.
3. Ishida S, Usui T, Yamashiro K, Kaji Y, Amano S, et al. (2003) VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med 198: 483-489. (Pubitemid 36976059)
4. Avunduk AM, Cetinkaya K, Kapicioglu Z, Kaya C (1997) The effect of posterior vitreous detachment on the prognosis of branch retinal vein occlusion. Acta Ophthalmol Scand 75: 441-442. (Pubitemid 27470477)
5. Moravski CJ, Kelly DJ, Cooper ME, Gilbert RE, Bertram JF, et al. (2000) Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertension 36: 1099-1104.
6. Campochiaro PA (2013) Ocular neovascularization. J Mol Med (Berl) 91: 311-321.
7. Ali Rahman IS, Li CR, Lai CM, Rakoczy EP (2011) In vivo monitoring of VEGF-induced retinal damage in the Kimba mouse model of retinal neovascularization. Curr Eye Res 36: 654-662.
8. Chen P, Yin H, Wang Y, Xie L (2012) Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1alpha in a mouse model of closed eye contact lens wear. Mol Vis 18: 864-873.
9. Hewing NJ, Weskamp G, Vermaat J, Farage E, Glomski K, et al. (2013) Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice. Invest Ophthalmol Vis Sci 54: 864-870.
10. Lofqvist C, Willett KL, Aspegren O, Smith ACH, Aderman CM, et al. (2009) Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice. Investigative ophthalmology & visual science 50: 1831-1837.
11. Vanhaesebrouck S, Daniëls H, Moons L, Vanhole C, Carmeliet P, et al. (2009) Oxygen-induced retinopathy in mice: amplification by neonatal IGF-I deficit and attenuation by IGF-I administration. Pediatric research 65: 307-310.
12. Lin M, Chen Y, Jin J, Hu Y, Zhou K, et al. (2011) Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Mü ller cells. Diabetologia 54: 1554-1566.
13. Xia X, Xiong S, Xu H, Jiang J, Li Y (2008) Suppression of retinal neovascularization by shRNA targeting HIF-1a. Current eye research 33: 892-902.
14. Bai Y, Bai X, Wang Z, Zhang X, Ruan C, et al. (2011) MicroRNA-126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors. Exp Mol Pathol 91: 471-477.
15. Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, et al. (2011) Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23-27-24 clusters. Proc Natl Acad Sci U S A 108: 8287-8292.
16. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414. (Pubitemid 46970709)
17. Meunier J, Lemoine F, Soumillon M, Liechti A, Weier M, et al. (2013) Birth and expression evolution of mammalian microRNA genes. Genome Res 23: 34-45.
18. Ahn HW, Morin F, Chen Z-J (2010) MicroRNA transcriptome in the newborn mouse ovaries determined by massive parallel sequencing.
19. Jeziorska M, Woolley DE (1999) Neovascularization in early atherosclerotic lesions of human carotid arteries: its potential contribution to plaque development. Hum Pathol 30: 919-925. (Pubitemid 29380515)
20. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, et al. (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66: 1095-1104. (Pubitemid 121001400)
21. Coveney D, Cool J, Capel B (2008) Four-dimensional analysis of vascularization during primary development of an organ, the gonad.
22. Shen J, Yang X, Xie B, Chen Y, Swaim M, et al. (2008) MicroRNAs regulate ocular neovascularization. Mol Ther 16: 1208-1216. (Pubitemid 351866051)
23. Small EM, Sutherland LB, Rajagopalan KN, Wang S, Olson EN (2010) MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. Circ Res 107: 1336-1344.
24. Kong YC, Sun B, Zhao KX, Han M, Wang YC (2013) Small interference RNA targeting vascular endothelial growth factor gene effectively attenuates retinal neovascularization in mice model. Chin Med J (Engl) 126: 1440-1444.
25. Yue X, Wang P, Xu J, Zhu Y, Sun G, et al. (2012) MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A. Oncol Rep 27: 1200-1206.
26. Zhang QQ, Xu H, Huang MB, Ma LM, Huang QJ, et al. (2012) MicroRNA-195 plays a tumor-suppressor role in human glioblastoma cells by targeting signaling pathways involved in cellular proliferation and invasion. Neuro Oncol 14: 278-287.
27. Dejean E, Renalier MH, Foisseau M, Agirre X, Joseph N, et al. (2011) Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas. Leukemia 25: 1882-1890.
28. Beck B, Driessens G, Goossens S, Youssef KK, Kuchnio A, et al. (2011) A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 478: 399-403.
29. Saint-Geniez M, Jiang A, Abend S, Liu L, Sweigard H, et al. (2013) PGC-1alpha regulates normal and pathological angiogenesis in the retina. Am J Pathol 182: 255-265.
30. Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, et al. (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4: 1565-1573.
31. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, et al. (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35: 101-111. (Pubitemid 24046832)
32. Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, et al. (2004) Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am J Pathol 165: 457-469. (Pubitemid 38971376)
33. Tong YC, Chang SF, Kao WWY, Liu CY, Liaw J (2010) Polymeric micelle gene delivery of bcl-xL via eye drop reduced corneal apoptosis following epithelial debridement. Journal of Controlled Release 147: 76-83.
34. Bai Y, Ma J, Guo J, Wang J, Zhu M, et al. (2009) Müller cell-derived VEGF is a significant contributor to retinal neovascularization. The Journal of pathology 219: 446-454.
35. Lin H, Chen W, Luo L, Wu C, Wang Q, et al. (2011) Cytotoxic effect of HIV-1 gp120 on primary cultured human retinal capillary endothelial cells. Mol Vis 17: 3450-3457.
36. Leske DA, Wu J, Fautsch MP, Karger RA, Berdahl JP, et al. (2004) The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP. Mol Vis 10: 43-50. (Pubitemid 38628978)
37. Donahue ML, Phelps Dl, Horowitz S (1996) Retinal vascular endothelial growth factor (VEGF) mRNA expression is altered in relation to neovascularization in oxygen induced retinopathy.
38. Leske DA, Wu J Fau, Fautsch MP, Lanier WL (2004) The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP.
39. Ben-Ami R, Albert ND, Lewis RE, Kontoyiannis DP (2013) Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis. J Infect Dis 207: 1066-1074.
40. Song JJ, Smith SK, Hannon GJ, Joshua-Tor L (2004) Crystal structure of Argonaute and its implications for RISC slicer activity. Science 305: 1434-1437. (Pubitemid 39167656)
41. Wilusz JE, Sharp PA (2013) Molecular biology. A circuitous route to noncoding RNA. Science 340: 440-441.
42. Meister G (2013) Argonaute proteins: functional insights and emerging roles. Nat Rev Genet 14: 447-459.
43. Sayed D, Abdellatif M (2011) MicroRNAs in development and disease. Physiol Rev 91: 827-887.
44. Kasinski AL, Slack FJ (2011) Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11: 849-864.
45. van Kouwenhove M, Kedde M, Agami R (2011) MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 11: 644-656.
46. Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379.
47. Lee RC, Ambros V (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science 294: 862-864. (Pubitemid 33032105)
48. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed RNAs. Science 294: 853-858. (Pubitemid 33032103)
49. Lau NC, Lim LP, Weinstein EG, Bartel DP (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862. (Pubitemid 33032104)
50. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, et al. (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408: 86-89.
51. Karali M, Manfredi A, Puppo A, Marrocco E, Gargiulo A, et al. (2011) MicroRNA-restricted transgene expression in the retina. PLoS One 6: e22166.
52. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, et al. (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. The Journal of neuroscience 15: 4738-4747.
53. Lamoke F, Labazi M, Montemari A, Parisi G, Varano M, et al. (2011) Trans-Chalcone prevents VEGF expression and retinal neovascularization in the ischemic retina. Experimental Eye Research 93: 350-354.
54. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613. (Pubitemid 26272112)
55. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676. (Pubitemid 36749215)
56. Dvorak HF, Brown LF, Detmar M Fau, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
57. Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, et al. (2003) VEGF164 is proinflammatory in the diabetic retina. Investigative ophthalmology & visual science 44: 2155-2162.
58. Kusari J, Zhou SX, Padillo E, Clarke KG, Gil DW (2010) Inhibition of Vitreoretinal VEGF Elevation and Blood-Retinal Barrier Breakdown in Streptozotocin-Induced Diabetic Rats by Brimonidine. Investigative ophthalmology & visual science 51: 1044-1051.
59. Liu F, Lou YL, Wu J, Ruan QF, Xie A, et al. (2012) Upregulation of microRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia/perfusion injury in vivo and in vitro. Kidney Blood Press Res 35: 182-191.
60. Sundermeier TR, Palczewski K (2012) The physiological impact of microRNA gene regulation in the retina. Cell Mol Life Sci.
61. Campochiaro PA, Nguyen QD, Shah SM, Klein ML, Holz E, et al. (2006) Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther 17: 167-176. (Pubitemid 43262032)
62. Ildefonso CJ, Kong L, Leen A, Chai SJ, Petrochelli V, et al. (2010) Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma. Mol Ther 18: 1885-1890.
63. Zhang L, Hou D, Chen X, Li D, Zhu L, et al. (2012) Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 22: 107-126.